Health Canada Approves Eurofins CDMO Alphora Inc.’s Cannabis Drug License for Synthetic Phytocannabinoids – Medical Marijuana Program Connection

LUXEMBOURG–(BUSINESS WIRE)–Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022. With the new Cannabis

Source link

• SEO Powered Content & PR Distribution. Get Amplified Today.
• PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
• PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
• PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
• PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
• Source: https://mmpconnect.com/health-canada-approves-eurofins-cdmo-alphora-inc-s-cannabis-drug-license-for-synthetic-phytocannabinoids/?utm_source=rss&utm_medium=rss&utm_campaign=health-canada-approves-eurofins-cdmo-alphora-inc-s-cannabis-drug-license-for-synthetic-phytocannabinoids